These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 9282935

  • 1. Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum.
    Cadogan AK, Alexander SP, Boyd EA, Kendall DA.
    J Neurochem; 1997 Sep; 69(3):1131-7. PubMed ID: 9282935
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus.
    Schlicker E, Timm J, Zentner J, Göthert M.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):583-9. PubMed ID: 9402037
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitro.
    Szabo B, Müller T, Koch H.
    J Neurochem; 1999 Sep; 73(3):1084-9. PubMed ID: 10461898
    [Abstract] [Full Text] [Related]

  • 12. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
    Derocq JM, Bouaboula M, Marchand J, Rinaldi-Carmona M, Ségui M, Casellas P.
    FEBS Lett; 1998 Apr 03; 425(3):419-25. PubMed ID: 9563506
    [Abstract] [Full Text] [Related]

  • 13. Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues.
    Stamer WD, Golightly SF, Hosohata Y, Ryan EP, Porter AC, Varga E, Noecker RJ, Felder CC, Yamamura HI.
    Eur J Pharmacol; 2001 Nov 23; 431(3):277-86. PubMed ID: 11730719
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Modulation of electrically evoked acetylcholine release through cannabinoid CB1 receptors: evidence for an endocannabinoid tone in the human neocortex.
    Steffens M, Szabo B, Klar M, Rominger A, Zentner J, Feuerstein TJ.
    Neuroscience; 2003 Nov 23; 120(2):455-65. PubMed ID: 12890515
    [Abstract] [Full Text] [Related]

  • 16. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.
    Shivachar AC.
    Biochem Pharmacol; 2007 Jun 15; 73(12):2004-11. PubMed ID: 17445778
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain.
    Burkey TH, Quock RM, Consroe P, Ehlert FJ, Hosohata Y, Roeske WR, Yamamura HI.
    Eur J Pharmacol; 1997 Oct 08; 336(2-3):295-8. PubMed ID: 9384246
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A.
    Gessa GL, Mascia MS, Casu MA, Carta G.
    Eur J Pharmacol; 1997 May 26; 327(1):R1-2. PubMed ID: 9185841
    [Abstract] [Full Text] [Related]

  • 20. Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist.
    Gallate JE, Saharov T, Mallet PE, McGregor IS.
    Eur J Pharmacol; 1999 Apr 16; 370(3):233-40. PubMed ID: 10334497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.